
Tavedro-A Tablet
Marketer
Ytiliga Private Limited
Salt Composition
Drotaverine (80mg) + Aceclofenac (100mg)
Overview Tavedro-A Tablet
Abdominal pain is effectively treated with the combined ingredients in A-Vedro tablets. This medication alleviates abdominal pain, bloating, discomfort, and cramping by relaxing stomach and intestinal muscles and inhibiting pain-inducing chemical signals. A-Vedro tablets should be taken with food, following your doctor's prescribed dosage and duration. Dosage is individualized based on your condition and response. Continue treatment as directed; premature discontinuation may cause symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common, typically transient side effects include diarrhea, nausea, vomiting, stomach ache, appetite loss, dry mouth, thirst, and heartburn. Report any concerning side effects immediately. Dizziness is a potential side effect; avoid driving or activities requiring alertness until its effects are known. Alcohol consumption should be avoided due to increased dizziness risk. Prior to commencing treatment, inform your physician of pregnancy, pregnancy plans, or breastfeeding. Disclosure of kidney or liver conditions is crucial for appropriate dosage determination.
Uses of Tavedro-A Tablet
Managing abdominal discomfort
Major Benefits of Tavedro-A Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Tavedro-A Tablet with a meal.
Common Side effects of Tavedro-A Tablet:
- Diarrhea
- Nausea
- Vomiting
- Dryness in mouth
- Dizziness
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Indigestion
- Abdominal pain
- Increased liver enzymes
How to use Tavedro-A Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Tavedro-A Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Tavedro-A Tablet works:
Tavedro-A Tablets combine Drotaverine and Aceclofenac to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets and reduces abdominal muscle spasms. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Tavedro-A Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Tavedro-A Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Tavedro-A Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Tavedro-A Tablet, a potential side effect of the medication, as it can induce vertigo.
KidneyCAUTION
Patients with kidney impairment should use Tavedro-A Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Tavedro-A Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Tavedro-A Tablets cautiously, potentially requiring dose modification. Severe hepatic dysfunction contraindicates Tavedro-A Tablet use. Physician consultation is essential. Regular liver function monitoring is recommended during treatment.
What if you forget to take Tavedro-A Tablet :
Should you forget a Tavedro-A Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tavedro-A Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
